Genflow Biosciences

(GENF)
Sector: Pharmaceuticals & Biotechnology
1.73p
-0.03p -1.43
Last updated: 11:00:43

Director dealings

Trade date Director Volume / Price Trade value Trade type
08/08/2022 Eric Leire 106,000 @ 2.80p £2,968.00 Buy
18/07/2022 Peter King-Lewis 82,000 @ 3.70p £3,034.00 Buy
18/07/2022 Yassine Bendiabdallah 108,000 @ 3.70p £3,996.00 Buy
18/07/2022 Eric Leire 308,999 @ 3.03p £9,362.67 Buy

Director shareholdings

Name Holding Percent
Eric Leire 120,414,999 41.00%
Yassine Bendiabdallah 470,500 0.00%
Peter King-Lewis 382,000 0.00%

Major shareholders

Institution name Holding Percent
MR ERIC LEIRE 124,414,999 35.60%
Premier Miton Group PLC 32,000,000 9.15%
Jonathan Mark Swann 17,586,000 5.03%
Adrian Beeston 17,550,400 6.00%
Samantha Bauer 14,500,000 4.96%
Longevity Tech Fund 10,499,998 3.59%